Skip to main content

Find Clinical Trials

Home
Conditions
Acquired amegakaryocytic thrombocytopenia

Clinical trial condition

Acquired amegakaryocytic thrombocytopenia

Explore clinical trials studying Acquired amegakaryocytic thrombocytopenia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Acquired amegakaryocytic thrombocytopenia trial results

Recruiting

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

NCT06412497

Conditions: Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Acquired amegakaryocytic thrombocytopenia, +11 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details